Xue Hu

589 total citations
21 papers, 422 citations indexed

About

Xue Hu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xue Hu has authored 21 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xue Hu's work include Genomics, phytochemicals, and oxidative stress (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cell death mechanisms and regulation (2 papers). Xue Hu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cell death mechanisms and regulation (2 papers). Xue Hu collaborates with scholars based in China, Singapore and United States. Xue Hu's co-authors include Jixiang Zhang, Dandan Wu, Jingjing Ma, Weiguo Dong, Jiao Li, Jing Yang, Lu Yin, Mu Yang, Tailang Yin and Gengxiang Wu and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Hypertension.

In The Last Decade

Xue Hu

20 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Hu China 13 184 66 56 49 47 21 422
Jeong‐Hwa Woo South Korea 13 154 0.8× 118 1.8× 38 0.7× 43 0.9× 63 1.3× 23 464
Bao Hou China 13 246 1.3× 57 0.9× 26 0.5× 53 1.1× 46 1.0× 30 524
Youyi Xiong China 14 238 1.3× 75 1.1× 43 0.8× 101 2.1× 59 1.3× 24 492
Yinzi Yue China 14 164 0.9× 32 0.5× 45 0.8× 61 1.2× 91 1.9× 32 396
Mahmood Husain Qazi Pakistan 13 253 1.4× 40 0.6× 61 1.1× 83 1.7× 21 0.4× 24 584
Feifei Nong China 10 300 1.6× 75 1.1× 37 0.7× 54 1.1× 42 0.9× 15 487
Mingjun Chen China 9 205 1.1× 51 0.8× 26 0.5× 60 1.2× 35 0.7× 20 413
Yongzhi Wang China 12 180 1.0× 83 1.3× 24 0.4× 31 0.6× 47 1.0× 21 475
Hongming Zheng China 11 278 1.5× 48 0.7× 32 0.6× 42 0.9× 27 0.6× 21 540

Countries citing papers authored by Xue Hu

Since Specialization
Citations

This map shows the geographic impact of Xue Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Hu more than expected).

Fields of papers citing papers by Xue Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Hu. The network helps show where Xue Hu may publish in the future.

Co-authorship network of co-authors of Xue Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Hu. A scholar is included among the top collaborators of Xue Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Hu. Xue Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xue, Baoliang Guo, Tong Sun, & Wan Wang. (2023). Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3. Open Medicine. 18(1). 20230635–20230635. 3 indexed citations
2.
3.
Hu, Xue, et al.. (2022). Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer. Frontiers in Pharmacology. 13. 814971–814971. 9 indexed citations
4.
5.
Hu, Xue, Fangzhou Jiao, Lan Zhang, & Yingan Jiang. (2021). Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway. Frontiers in Pharmacology. 12. 654986–654986. 16 indexed citations
6.
Hu, Xue, et al.. (2021). Massive Calcified Epithelioid Hemangioendothelioma With Multifocal Involvement: An Imaging Diagnosis Dilemma and a Rare Case Report. Frontiers in Oncology. 11. 782970–782970. 2 indexed citations
7.
Hu, Xue, et al.. (2021). Associations between ADIPOQ rs2241766 SNP and breast cancer risk: a systematic review and a meta-analysis. Genes and Environment. 43(1). 3 indexed citations
8.
Wu, Gengxiang, Xue Hu, Jinli Ding, & Jing Yang. (2019). Abnormal expression of HSP70 may contribute to PCOS pathology. Journal of Ovarian Research. 12(1). 74–74. 22 indexed citations
9.
Yang, Mu, et al.. (2019). Sulforaphane ameliorates high-fat diet-induced spermatogenic deficiency in mice†. Biology of Reproduction. 101(1). 223–234. 15 indexed citations
10.
11.
Ning, Ling, E. T. Kang, Yunbing Wang, Xue Hu, & Liqun Xu. (2018). Recent Developments in Controlled Release of Antibiotics. Current Pharmaceutical Design. 24(8). 911–925. 13 indexed citations
12.
Li, Jiao, Dandan Wu, Jixiang Zhang, et al.. (2018). Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells. World Journal of Gastroenterology. 24(17). 1901–1910. 33 indexed citations
13.
Yang, Mu, Tailang Yin, Lu Yin, Xue Hu, & Jing Yang. (2018). CTRP3 attenuates high-fat diet-induced male reproductive dysfunction in mice. Clinical Science. 132(8). 883–899. 26 indexed citations
14.
15.
Ma, Jingjing, Xufeng Guo, Jixiang Zhang, et al.. (2017). PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3β/β-Catenin Signaling Pathway in Human Gastric Cancer. Digestive Diseases and Sciences. 62(12). 3415–3425. 37 indexed citations
16.
Hu, Xue, Jingjing Ma, Vikash Vikash, et al.. (2017). Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway. Digestive Diseases and Sciences. 63(1). 126–134. 28 indexed citations
17.
18.
Hu, Xue. (2015). Efficacy and prognostic factors of cyberknife treatment combined with transcatheter arterial chemoembolization therapy for primary liver cancer.
19.
Hu, Xue, Wenchao Dou, Linglin Fu, & Guangying Zhao. (2012). A disposable immunosensor for Enterobacter sakazakii based on an electrochemically reduced graphene oxide-modified electrode. Analytical Biochemistry. 434(2). 218–220. 18 indexed citations
20.
Wu, Hong, et al.. (2010). Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.. PubMed. 123(20). 2908–13. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong‐Hwa Woo Breakdown of academic impact, for papers by Bao Hou Breakdown of academic impact, for papers by Youyi Xiong Breakdown of academic impact, for papers by Yinzi Yue Breakdown of academic impact, for papers by Mahmood Husain Qazi Breakdown of academic impact, for papers by Feifei Nong Breakdown of academic impact, for papers by Mingjun Chen Breakdown of academic impact, for papers by Yongzhi Wang Breakdown of academic impact, for papers by Hongming Zheng
Rankless by CCL
2026